Remedy for 340B-Acquired Drug Payment Policy Proposed Rule Summary

CMS released a proposed rule (CMS-1793-P) on July 7, 2023, that describes the Agency’s proposed actions to craft a remedy relating to the adjustment of Medicare payment rates for drugs acquired under the 340B Program from calendar year 2018 through September 27, 2022, following a remand from the United States District Court for the District of Columbia and the United States Supreme Court’s decision in American Hospital Association v. Becerra. The proposed rule was published in the July 11, 2023, issue of the Federal Register. The public comment period will end on September 5, 2023. CMS indicates that the final rule will be published by September 27, 2023.